Search results
AstraZeneca's COVID vaccine withdrawn—it was a victim of misinformation right to the end, researcher...
Medical Xpress· 58 minutes agoThis development has been covered in various media outlets as primarily related to the known...
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street...
Motley Fool via Yahoo Finance· 8 hours agoFood and Drug Administration. This combo vaccine would almost certainly be a better revenue driver...
Novavax (NVAX) Set to Announce Quarterly Earnings on Friday
ETF DAILY NEWS· 15 hours agoNovavax (NASDAQ:NVAX – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Friday, May 10th. Analysts expect the company to announce ...
Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational...
WKRN Nashville· 2 days agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its first quarter ...
Shah Capital urges Novavax shareholders to vote against three directors
Reuters via AOL· 3 days ago(Reuters) -Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
CORRECTED-UPDATE 3-Novavax's top shareholder Shah Capital ramps up efforts for board shakeup
Reuters via Yahoo Finance· 3 days agoShah Capital, which currently owns a near 7.5% stake in Novavax and is its third-largest shareholder, reiterated that the company was "undervalued
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 3 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Zacks· 1 week agoFree Report) closed at $4.33, marking a +0.93% move from the previous day. Shares of the vaccine maker have depreciated by 7.74% over the course of the past month, underperforming ...
Novavax (NVAX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) possesses the right combination of the two key ingredients for a likely earnings beat...
An adjuvant made in yeast could lower vaccine cost and boost availability
UC Berkeley NewsCenter· 1 day agoVaccines save lives, as proven during the recent pandemic, but one component of most vaccines —...